@article{cb063d2d1a544db7909b51e9decfc8b3,
title = "BMI is positively associated with accelerated epigenetic aging in twin pairs discordant for body mass index",
abstract = "Background: Obesity is a heritable complex phenotype that can increase the risk of age-related outcomes. Biological age can be estimated from DNA methylation (DNAm) using various “epigenetic clocks.” Previous work suggests individuals with elevated weight also display accelerated aging, but results vary by epigenetic clock and population. Here, we utilize the new epigenetic clock GrimAge, which closely correlates with mortality. Objectives: We aimed to assess the cross-sectional association of body mass index (BMI) with age acceleration in twins to limit confounding by genetics and shared environment. Methods and results: Participants were from the Finnish Twin Cohort (FTC; n = 1424), including monozygotic (MZ) and dizygotic (DZ) twin pairs, and DNAm was measured using the Illumina 450K array. Multivariate linear mixed effects models including MZ and DZ twins showed an accelerated epigenetic age of 1.02 months (p-value = 6.1 × 10–12) per one-unit BMI increase. Additionally, heavier twins in a BMI-discordant MZ twin pair (ΔBMI >3 kg/m2) had an epigenetic age 5.2 months older than their lighter cotwin (p-value = 0.0074). We also found a positive association between log (homeostatic model assessment of insulin resistance) and age acceleration, confirmed by a meta-analysis of the FTC and two other Finnish cohorts (overall effect = 0.45 years, p-value = 4.1 × 10–25) from adjusted models. Conclusion: We identified significant associations of BMI and insulin resistance with age acceleration based on GrimAge, which were not due to genetic effects on BMI and aging. Overall, these results support a role of BMI in aging, potentially in part due to the effects of insulin resistance.",
keywords = "aging, BMI, epigenetic clock, GrimAge, HOMA-IR, obesity",
author = "Sara Lundgren and Sara Kuitunen and Pietil{\"a}inen, {Kirsi H.} and Mikko Hurme and Mika K{\"a}h{\"o}nen and Satu M{\"a}nnist{\"o} and Markus Perola and Terho Lehtim{\"a}ki and Olli Raitakari and Jaakko Kaprio and Miina Ollikainen",
note = "Funding Information: This research was supported by the FP7‐HEALTH‐F4‐2007, grant agreement number 201413 for European Network for Genetic and Genomic Epidemiology; EU Horizon 2020 (grant 755320 for TAXINOMISIS and grant 848146 for To Aition); Tampere University Hospital Supporting Foundation; Finnish Society of Clinical Chemistry; Yrj{\"o} Jahnssonin S{\"a}{\"a}ti{\"o}; Paavo Nurmen S{\"a}{\"a}ti{\"o}; Helsinki University Hospital; Emil Aaltosen S{\"a}{\"a}ti{\"o}; Tampereen Tuberkuloosis{\"a}{\"a}ti{\"o}; Sigrid Juselius Foundation; Diabetestutkimuss{\"a}{\"a}ti{\"o}; Novo Nordisk Fonden NNF10OC1013354, NNF17OC0027232; Syd{\"a}ntutkimuss{\"a}{\"a}ti{\"o}; Diabetes Research Foundation of Finnish Diabetes Association; Signe ja Ane Gyllenbergin S{\"a}{\"a}ti{\"o}; Juho Vainion S{\"a}{\"a}ti{\"o}; Suomen L{\"a}{\"a}ketieteen S{\"a}{\"a}ti{\"o}; Social Insurance Institution of Finland; European Research Council (grant 742927 for MULTIEPIGEN project); Suomen Kulttuurirahasto; Academy of Finland (grant numbers 100499, 117787, 118555, 121584, 124282, 126925, 129378, 129680, 134309, 141054, 205585, 213506, 255935, 263278, 264146, 265240, 266286, 272376, 286284, 297908, 308248, 312073, 314383, 322098, and 41071); Competitive State Research Financing of the Expert Responsibility area of Kuopio; Tampere and Turku University Hospitals X51001; National Institute of Alcohol Abuse and Alcoholism (grants AA‐00145, AA‐09203, and AA‐12502); Helsingin ja Uudenmaan Sairaanhoitopiiri; Helsingin Yliopisto. Publisher Copyright: {\textcopyright} 2022 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.",
year = "2022",
doi = "10.1111/joim.13528",
language = "English",
volume = "292",
journal = "JOURNAL OF INTERNAL MEDICINE",
issn = "0954-6820",
publisher = "Wiley",
number = "4",
}